168 related articles for article (PubMed ID: 2266262)
1. Labetalol and nifedipine in the management of essential hypertension.
Prasad NK
J Indian Med Assoc; 1990 Jul; 88(7):188-9. PubMed ID: 2266262
[TBL] [Abstract][Full Text] [Related]
2. Treatment of isolated systolic hypertension with labetalol in the elderly.
Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension in the elderly. Comparison of the efficacy and tolerability of labetalol and nifedipine. A multicenter, randomized, single-blind study].
Decoulx M; Godon P; Pappo M; d'Allens H
Ann Cardiol Angeiol (Paris); 1990 May; 39(5):305-9. PubMed ID: 2195978
[TBL] [Abstract][Full Text] [Related]
5. Slow-release metoprolol and nifedipine in essential hypertension: 24 hour noninvasive ambulatory blood pressure monitoring.
Lattuada S; Antivalle M; Rindi M; Montanari M; Alberti D; Libretti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S99-101. PubMed ID: 2455155
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
8. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
9. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
[TBL] [Abstract][Full Text] [Related]
10. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
[TBL] [Abstract][Full Text] [Related]
11. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension.
Faust G
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S56-61. PubMed ID: 1283191
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled, crossover trial to investigate the additive hypotensive effect of a diuretic (mefruside) to that produced by nifedipine.
Poulter N; Thompson AV; Sever PS
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S53-6. PubMed ID: 2455140
[TBL] [Abstract][Full Text] [Related]
13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
14. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of methyldopa and labetalol in the treatment of hypertension.
Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
[TBL] [Abstract][Full Text] [Related]
16. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
Chalmers AG; Hunter J; Lees CD; Millar JA; Brown JJ; Robertson JI
Br J Clin Pharmacol; 1979; 8(Suppl 2):183S-187S. PubMed ID: 526399
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
18. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
[TBL] [Abstract][Full Text] [Related]
19. [Essential arterial hypertension and quality of life. Comparative crossed double-blind study of labetalol and captopril].
Carre A; Petetin N; Jouvent R; Baruch P; d'Allens H; Pappo M
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1269-73. PubMed ID: 2510660
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of atenolol and labetalol in essential hypertension--a double blind cross over trial.
Srivastava SC; Jagdish ; Katyal VK; Singh H; Mohan R
Indian Heart J; 1989; 41(4):256-60. PubMed ID: 2807362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
